InvestorsHub Logo
Followers 8
Posts 628
Boards Moderated 0
Alias Born 05/26/2021

Re: None

Friday, 07/30/2021 10:57:08 AM

Friday, July 30, 2021 10:57:08 AM

Post# of 13741
Escozine :)
A good read for those newly learning about Medolife rx Aelia QNTA .. or a good reread for longs … nice to be reminded of just how far reaching the potential is for this companies innovative science

https://www.nasdaq.com/press-release/medolife-rx-announces-historic-product-registration-in-dominican-republic-enabling

“This registration not only validates Escozine® as a cancer therapeutic but creates an unbelievable revenue generation opportunity for our company in that the product can be off-label prescribed for treatment of COVID-19 patients as a supportive therapy where vaccination progression has been slow,” said Medolife CEO Dr. Arthur Mikaelian. “Through free trade agreements, we will be able to market Escozine to one of the largest populations in the world. Cancer remains one of the leading causes of death worldwide and estimates have shown between four and five percent of humans will develop cancer in their lifetime. It is our mission to reach these patients with our polarized drug Escozine and improve their quality of life while helping to fight the cancer itself, and we are now registered to do so.”

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.